elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Nasopharyngeal carcinoma
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Nasopharyngeal carcinoma
RIS
0.001
(Research Intensity Score)
Papers
71
Top papers
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
2021 · 461 citations
Hypoxia-tropic delivery of nanozymes targeting transferrin receptor 1 for nasopharyngeal carcinoma radiotherapy sensitization
2025 · 51 citations
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment
2023 · 110 citations
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
2019 · 948 citations
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial
2025 · 36 citations
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma
2025 · 26 citations
METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis
2025 · 22 citations
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial
2025 · 17 citations
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
2018 · 507 citations
Newest papers
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
2026 · 5 citations
Consolidative Radiotherapy After Gemcitabine‐Platinum Chemotherapy in De Novo Metastatic Nasopharyngeal Carcinoma: Impact of Chemotherapy Backbone and Prognostic Factors on Survival
2026
Hypoxia from fractionated radiotherapy drives spatiotemporal CD8+ T cell exhaustion by KDM5A-dependent silencing of TCF1 in nasopharyngeal carcinoma
2026
Conditional diffusion models for high-fidelity synthetic CT generation from CBCT in nasopharyngeal carcinoma adaptive radiotherapy: a multi-center study
2026
Adjuvant apatinib therapy following concurrent chemoradiotherapy in patients with high-risk nasopharyngeal carcinoma: A multicenter, prospective phase 2 study
2026
IVIM-DWI Noninvasively Assesses Tumor-Infiltrating Lymphocytes and Correlates with Immunotherapy Prognosis in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma
2026
Risk factors for severe radiation-induced dermatitis in nasopharyngeal carcinoma patients undergoing radiotherapy
2026
Does Glucose-6-Phosphate Dehydrogenase Deficiency Correlate with Increased Sensitivity to Cisplatin? A Case Report and a Narrative Literature Review
2026 · 1 citations
Longitudinal multi-b-value diffusion MRI for the early assessment of radiation-induced parotid injury in nasopharyngeal carcinoma
2026
Browse all papers →
Nasopharyngeal carcinoma's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Nasopharyngeal carcinoma's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link